ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

NUT Neutrahealth

6.50
0.00 (0.00%)
10 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Neutrahealth LSE:NUT London Ordinary Share GB00B062Q126 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 6.50 - 0.00 01:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
0 0 N/A 0

Neutrahealth Share Discussion Threads

Showing 126 to 150 of 375 messages
Chat Pages: 15  14  13  12  11  10  9  8  7  6  5  4  Older
DateSubjectAuthorDiscuss
08/12/2006
00:52
Major Shareholders
NeutraHealth PLCMajor ShareholdersShares in issue:140.8m10p Ords Name Amount % Holding
Rathbone Investment Management Ltd 17,100,000 12.15
Singer & Friedlander Group PLC 8,585,250 6.10
Hargreave Hale & Co 7,450,000 5.29
Framlington Investment Management Ltd 6,450,000 4.58
Artemis Investment Management 6,450,000 4.58
Octopus Asset Management 5,285,000 3.75
RAB Capital PLC 5,100,000 3.62
Stlrling J K Esq 4,761,905 3.38
Stlrling S L Mrs 4,761,905 3.38
Aberdeen Asset Mgmnt 4,686,683 3.33
Fidelity Investment Services Limited 4,372,700 3.11
Other Directors Name Amount % Holding
Gulam Kaderbhoy Noon(dup) 4,047,618 2.875
Anthony Bruton Good 3,952,380 2.807
Salvatore Martin Gatto 2,428,571 1.725
Raymond ALbert Hill 197,619 0.140
Robin David Hilton 25,000 0.018
Michael Hjelm Toxvaerd 1
= Director

daveperry
07/12/2006
13:45
Back after some lunch and it is looking good! A lot of the buy trades today are reported as unknown or sells. The 50k and 100k after my 23k buy are definitely buys and are what caused the price rise. All looking good. Think I will go away now because I'm in danger of being on here all day. Good luck all!
mattyfromtheblock
07/12/2006
12:00
I'm in for a starting chunk of 23k. Lets get this back up in the teens. Got a great price at 8.45p aswell!
mattyfromtheblock
07/12/2006
11:55
Well millsig, u were right that it was good news for holders! Lol.

NeutraHealth Plc
07 December 2006


7 December 2006


NEUTRAHEALTH PLC ('the Company')


NATIONWIDE DISTRIBUTION OF RETAIL PRODUCTS


NeutraHealth is pleased to make the following announcement regarding significant
developments in penetrating the UK retail market

The Company has reached agreement with Boots the Chemist plc, Waitrose, Harrods,
Selfridges, Holland & Barrett, and The Nutri Centre (51% owned by Tesco)
resulting in the newly launched TravelGuard range of products being available
nationwide. These retailers account for more than half of the VMS market in the
UK. The launch of the brand, which started in November, will continue this
month in Holland & Barrett and, fitting in with range review timings, will
continue to be rolled out across national outlets in early 2007. Negotiations
are ongoing with other major retailers.

The innovative products, TravelGuard, CabinGuard and SolarGuard, provide an
uncompromising combination of science, research and naturally sourced high
quality ingredients. They offer the traveller, whether on business or leisure,
natural choices to help support and maintain circulatory, gastro-intestinal and
skin health whilst travelling and when abroad. Plans for extending the range
into further lifestyle products are already well advanced.

The Company has also agreed a licensing deal with a well-known health and beauty
brand to launch an exciting new range of products for consumers nationwide in
first half 2007.

In addition group company BioCare Ltd has recently launched BioCare Professional
Plus, a unique and sophisticated range providing advanced and innovative
formulations for customers and healthcare practitioners.

Michael Toxvaerd, Neutrahealth Chief Executive, commented:

'The agreements announced today represent a significant step forward in the
product ranges offered across the NeutraHealth group, and underlines the organic
growth potential over the next year. Following the disappointing summer, autumn
sales have returned to expected levels so the prospects for the group look
strong as we move into 2007 and continue on our strategy of acquiring good
businesses with growth opportunities.'


For more information:

Further information for investors is available on the Company's website at

www.neutrahealthplc.com/


NeutraHealth plc
Martin Gatto, Chairman 07778 749 223
Michael Toxvaerd, Chief Executive 07730 581 584
Robin Hilton, Finance Director 07738 018 411

KBC Peel Hunt
Matt Goode 020 7418 8900

Pelham Public Relations
James Henderson 020 7743 6672
Gavin Davis 020 7743 6677




This information is provided by RNS
The company news service from the London Stock Exchange


I am now even more tempted. Can see approx. 40% in this while it gets back to previous levels of 12-13p as trading picks up. Very positive RNS. Hope ur other investment serves u well millsig mate

mattyfromtheblock
06/12/2006
23:05
I think they are caught up with the general downturn in the high street. In addition they are not really surging forward. Steady growth is just not good enough these days.
kerpen01
06/12/2006
18:12
Hi Matty, I sold mine yesterday morning. I needed funds for a more tempting prospect and these were top of my list for selling. This should be good news for holders, because with my luck, they usually start going up after I sell!
;-)

millsig
05/12/2006
16:22
Sharp downturn today to an all-time low share price The price looks very tempting considering the main bad point of the trading statement was the one off costs that they incurred which are not a concern in the long term. With trading supposedly picking up I think I will contact the company to see what is going on as I am now looking to buy a large chunk of shares after all this waiting. I also noticed that the recent grant of share options to Mr James McEuen are only exercisable if the share price is over 20p in two years which must say something for the boards' confidence (unless they just never want the options to be exercised!!). Would love to know what you lot think of the downturn today.
mattyfromtheblock
01/12/2006
21:17
From Matty's heading:

"With proposed profits expected to grow to £1.6m this year and with such a high rate of growth within the company, a Market Cap of £18m is extremely low. The share price hit 25p when the company had a lot less than they do now."

From the link in post 12:

"The company has released no figures at this time, but for the first half of the year it reported a total turnover of £4.3m (c €6.3m) and operating profit of £0.75m (€1.1m).

"Gatto said that NeutraHealth has yet to finish building its base of companies from which it will seek to grow organically, and expects to make two or three more acquisitions in the next couple of years."

OK, comments like "abortive acquisition" and "weak summer" may scare a few off and lack of news tends to increase downward pressure, but market cap is now a mere £11.4m.

Market to book ratio is only 0.85 and one-off costs (see post 11), amount to only £0.35m, compared to cash & securities of £2.28m. Meanwhile, more aquisitions are on the cards.

So, things may get worse before they get better (for the share price), but I hope to top before 28 Feb 2007, as I suspect the results won't be as bad as feared.

millsig
31/10/2006
17:44
9.5% drop today - 30% drop over 12 months.
Maybe a placing is imminent, to fund another aquisition?

millsig
24/10/2006
12:47
"NeutraHealth initiatives act as shield from summer slump"
millsig
23/10/2006
18:50
NeutraHealth expects to meet 2007 targets after signs of improved trading

LONDON (AFX) - NeutraHealth PLC said that it is confident that it will deliver on 2007 expectations after signs of improved trading.

In a trading update, the AIM-listed nutraceutical acquisition firm said it expects second-half sales to mirror those in the first half, unlike in 2005 when sales fell 7 pct in the final half over the first six months.

Sales initiatives "are achieving greater success as they mature", said the firm. These initiatives include this month's launch of a TravelGuard range, which the firm hopes to distribute nationwide by the first quarter of 2007.

However, the firm said the results for 2006 will include a number of one-off
costs: 100,000 stg in employee termination costs at the BioCare unit, 99,000 stg in relocation and set-up costs after the Nutrigold acquisition, and 150,000 stg abortive acquisition costs.

Commenting on trading, chief executive Michael Toxvaerd said: "Whilst we are
disappointed to report the one-off costs, it is pleasing that our trading
business is coming back after a weak summer. We have put in place the building
blocks to ensure growth in 2007 and we are confident about the future."

Martin Gatto, NeutraHealth chairman, said: "The management team has
performed well in overcoming the poor trading conditions in the industry, and
the company is well placed to deliver further growth."

millsig
06/8/2006
20:08
There should be some interest in NUT tomorrow (Monday) following a BUY recommendation in this months Small Company Share Watch, out over the weekend.
blackrabbit
25/7/2006
11:06
Some good looking interims. Growth is looking very sustainable and the Biocare website is already contributing 4% to the company's bottom line. Plenty of organic growth available and with 100% increase in European exports (mainly with existing clients) it shows that the distributors are coming back for more and more so their must be a healthy market for their products out there. Still on the sidelines as I think this could drop a little soon but I am looking forward to getting into this company and holding!
mattyfromtheblock
25/7/2006
11:02
NeutraHealth Plc
25 July 2006


25 July 2006


NEUTRAHEALTH PLC ('the Company')

2006 INTERIM RESULTS STATEMENT

NeutraHealth Plc, which was admitted to trading on AIM in February 2005 to
acquire companies in the nutraceutical industry, today announces its interim
results for the six months to 30 June 2006.

The Company has had a successful first half of the year, with results in line
with our expectations. Following the cornerstone acquisition of BioCare in 2005,
the Company made a bolt-on acquisition of Nutrigold in February 2006. These two
companies are fully integrated into the NeutraHealth group, and a strong
platform for sustainable growth is in place.

The Company is confident that initiatives put in place during the last six
months will deliver further growth through the second half of the year while the
Company continues to strengthen relationships with acquisition targets.

Financial Highlights

• Total turnover £4.3m
• BioCare sales growth from 2nd Half 2005 9%
• EBITDA * £1.0m
• Cash Reserves £1.9m

No trading comparatives are presented above as the group's trading activity
started in August 2005 with the acquisition of BioCare Limited.

* EBITDA excluding share options charge and one off costs of £11,000 incurred on
aborted acquisitions, and £99,000 incurred in relocating and integrating
Nutrigold into the existing group.


Operational Highlights

• Acquisition of Nutrigold in February 2006 followed by successful
integration of operations into existing facilities
• Launch of BioCare transactional website in April 2006 with 85% of direct
consumer orders being new customers
• 10 new products launched since December
• Significant interest in BioCare range and Nutrigold Detox products in 15
overseas markets
• Appointment of 12 nutritionists nationwide to complement the BioCare
customer development team

BioCare

BioCare has had a strong six months after being acquired by NeutraHealth last
year. Since the appointment of James McEuen as Managing Director in November
2005, he has successfully implemented many initiatives that have combined to
deliver sales growth of 9% for the last six months, compared with the period
from July to December 2005. This growth in sales is expected to continue over
the next six months as the improvements to the business take full effect.

Exports

BioCare has always had a strong reputation as a leading brand in the
practitioner channel in the UK. The potential to become a leading European brand
focussing on practitioners was identified as a key opportunity at the time of
acquisition. The company has made progress in developing the European market
with exports increasing over 100% year on year predominately through business
with existing overseas distributors, but also through a number of new
relationships.

UK Customer Development

A UK Customer Development department has been created, and 12 trained
nutritionists have been appointed to provide a nationwide network of sales
ambassadors and company advocates to other practitioners and health food stores.
These ambassadors will play a crucial role in educating customers about the
BioCare range, and initial feedback has been very encouraging.

Website

BioCare launched its retail website in April 2006 and has had an encouraging
response with 85% of all direct consumer orders received so far being placed by
new Biocare customers. The internet already accounts for over 4% of monthly
revenue, allowing the business to serve an increasing customer base without
increasing the number of sales order staff.

Product Launches

A number of exciting new products have been launched in the last six months.
These have included advanced product formulations, and also developments that
have focused on delivery of the product. For instance our biggest selling
probiotic product Bio-Acidophilus has just been launched both in straws and as a
powder with the emphasis on expanding our share of the market for child friendly
probiotics.

The launch of our innovative lifestyle range is now expected in Autumn this
year. We suspended our launch while NeutraHealth pursued retail brand
acquisition targets. The deferment of our original plans is expected to cause
less than 2% reduction in anticipated growth this year. Following withdrawal
from the acquisition processes, we resumed development of a new brand, which is
now complete. Discussions with major high street retailers are ongoing and
progressing well.

Our product launches so far this year include:

OmegaBerry A new fatty acid providing omega 3 fatty acids from fish,
flavoured with natural berries that makes the product more tasty
and attractive to children

Omega Oils A new fatty acid providing a full range of omega 3, 6 & 9 fatty
acids from linseed, olive, evening primrose & sesame oils,
rather than fish oils. It can be used as an alternative salad
dressing

VascularGuard Carefully selected antioxidants to help support the healthy
function of the cardiovascular system

VitaCell An antioxidant supplement to help protect the skin against
excessive exposure to the sun

Salvesterol A plant extract that is the vital ingredient behind the advice
to consume five portions of fruit & vegetables each day

Sterolvite Plant extracts to help maintain healthy cholesterol levels

MindLinx A synergistic combination of l-glutamine & special probiotics
supporting the gut-brain connection

Our product development pipeline remains sound with several more launches
planned for 2006.

Sage Organic

BioCare has recently become sole distributor for the Sage Organic product range.
Sage has a unique range of food supplements including Health Man, Healthy Woman
and Menopause dual packs (combinations of multivitamins and herbal remedies)
that are stocked in selected Boots and Waitrose stores in the UK.

Nutrigold

Nutrigold was acquired in February this year for £500,000 (with an earn out
potential of up to a further £300,000). This was identified as a complementary
bolt-on acquisition with the opportunity to realise synergies through
co-locating order fulfilment and administrative functions.

Nutrigold has now been fully integrated into NeutraHealth's facilities in
Birmingham and despite this period of change the company has continued to
perform to our expectations, delivering sales of £335,000 in the first four
months. The operational synergies are being achieved, and Nutrigold management
activity is now firmly focussed on driving sales.

We are experiencing an increasing interest in the Nutrigold products. In
particular the Amanda Hamilton/Nutrigold Detox range is receiving a lot of
interest from UK customers and overseas distributors.

Outlook

NeutraHealth remains committed to making acquisitions that will deliver value to
shareholders. In the first half of 2006 this resulted in the acquisition of
Nutrigold as well as abortive fees from withdrawing from acquisition processes
that failed to meet our value criteria.

In the second half of the year the Board will continue to work on building
relationships and assessing potential acquisitions that will help deliver the
Company's strategic aims while the group continues to deliver strong organic
growth through existing and new brands.


Michael Toxvaerd, NeutraHealth Chief Executive, commented:

'We are pleased with the group performance for the first half of the year.
Strong profitable sales growth has been achieved quickly after acquisition. We
expect initiatives launched during the first half of the year to have a
significant impact during the second half of the year as well.

Cashflow generation from operations remains good, and growth in earnings meets
our expectations for this period. We are looking forward to further success this
year with our existing businesses as we continue to assess acquisition
opportunities.'

mattyfromtheblock
06/7/2006
12:03
For any of you guys interested in this sector (nutraceuticals and health etc.) then you might fancy a look at Alltracel Pharmaceuticals (AP.) aswell. Released a very upbeat Q2 Trading update this morning and have some exceptional products with which the company is set for some strong organic growth. I must point out that I myself invested in them this morning so I do have an interest in them. Have monitored them for a while and now they are swining into profitability and wih strong growth ahead I think it is the right time to get in (while it is at near low prices). This is not a ramp, just a piece of information for you lot as I'm guessing you (like me) have an interest in this growing sector. Would like to know what you lot think.
mattyfromtheblock
05/7/2006
16:19
Small downturn today on the bid. I'm being very stingey with my buy in price and want to get in at around 13p. Got no doubts about this company and where it is heading. Interims on July 25th might provide a little boost as the market has a chance to view operations. Just want that 13p though! LOL
mattyfromtheblock
27/6/2006
15:53
Bought in today, hoping for a good return!!
philipmidgley
23/6/2006
15:12
I'm sure others will notice it soon - it's top of the sector heatmap on iii at the moment - the same sector as Tesco!
millsig
23/6/2006
14:33
Thanks millsig, have added it to the header. Surprised this share gets such little attention. I'm sure we will have more interest as people start to realise what the company is all about and how they are going to move forward.
mattyfromtheblock
23/6/2006
14:14
Matty - thanks for the thread; excellent introduction.

It seems NeutraHealth have another website too: www.neutrahealthplc.com
Perhaps you could add this in the header?

Some key dates from the website:

25 July 2006
Interim Results 2006

31 December 2006
Financial year end

06 March 2007
Preliminary announcement for the year ended 31 December 2006

millsig
20/6/2006
12:42
I also forgot to mention the management, who are and will be the most important asset in the company's success. All of the directors are extremely experienced and all have their individual stengths that they bring to the company. Martin Gatto is extremely good at turning companies around who are in trouble and has done so before with such companies as British Energy and Somerfield. This means that he will be very careful with the company's money and should not let the company get into a bad financial position. Michael Toxvaerd has worked is many high growth businesses and knows how to implement strategies to grow market share and increase distribution networks. Anthony Good is a public relations specialist which means that the company will treat the customers well, which will increase the company's reputation in the public domain to no end. Raymond Hill has considerable experience as a health food retailer, distributor and mail order operator and so he has considerable knowledge within the sector. Sir Gulam Noon, MBE is an extremely well known and respected business man who will add vast experience to the board. With the acquisitons of BioCare and NutriGold we now have more, successful directors on the board. We have a perfect balance of executive and non-executive directors and so the shareholders' interests will always be at the forefront of every company decision. Many of the board own shares in NUT as well and so will further be acting in our interest.
mattyfromtheblock
20/6/2006
12:22
Ok I have put up a new thread for this outlining the company fully for any potential new investors. Feel free to start using that thread if preferred. Take care
mattyfromtheblock
20/6/2006
12:10
NeutraHealth came to the market in February 2005 as a cash shell looking to acquire cash generative companies with positive growth potential. To date they have delivered on exactly what they proposed they would do. In August 2005 they acquired BioCare who are an established developer and distributor of natural healthcare products. In February 2006 they further developed the company by acquiring Nutrigold Limited, which produces a range of nutraceutical products and services for the practitioner market. Both companies are producing a profit and are both fully integrated into the company's Birmingham premises.

The Telegraph rated NUT as a 'Buy' under a month ago saying:
"Diet supplement specialist Neutra-Health's sales are expected to grow from £2.4m last calendar year to £9.3m this year and profit is expected to grow from £400,000 to £1.6m. The nutraceuticals sector is growing by 10 to 15% a year. The company will launch branded travel products into the retail market later this year."

As highlighted in the above paragraph the nutraceuticals sector is growing by 10 to 15% a year. This may well increase as more emphasis is placed on healthy living and vitamin supplementation.

NeutraHealth is successfully implementing its strategy of driving consolidation in the industry by acquiring cornerstone investments and making bolt on acquisitions to these. A recent trading update (layed out below) outlines the company's success and growth prospects.

• Exports up 102% year on year (first four months 06) with the majority into
Europe and the Middle East
• Initial discussions progressing with new distributors in 5 key European
markets
• 9 new products launched since December with specific focus on child
friendly applications
• Significant UK and overseas distributor interest in the Amanda Hamilton /
Nutrigold Detox range
• On-line purchasing website launched with 85% of direct consumer orders new
to BioCare
• Appointment of 12 nutritionists nationwide to complement the BioCare
customer development team

The best thing is that although the company is looking to consolidate the market further and gain further market share this way, much of their growth will be organic through realisation of new distributors and increased exports. The fact that 85% of customers who ordered on their new online sales website are completely new customers just goes to show how this company is growing. The website has also only been up for 2 months so this figure will grow without a doubt. It is well layed out and very professional and extremely easy to navigate. The website is:

www.biocare.co.uk

NeutraHealth's website address is as follows:

www.neutrahealthplc.com

With proposed profits expected to grow to £1.6m this year and with such a high rate of growth within the company, a Market Cap of £18m is extremely low. The share price hit 25p when the company had a lot less than they do now. Once it had settled, it still hit 23p. The draw back in price is totally un-founded except for the fact that the company is not on many people's radars yet, but believe me it will be! This could easily get back to 23p and with further consolidation of the sector they will no doubt become a major player. A definite 'Buy and Hold'.

mattyfromtheblock
19/6/2006
14:16
Just been researching this company this morning. Looks very interesting, especially when I look at the trading today. Going to do more research throughout the day. Would anyone have any objections for me to create a new thread with a more informative header? (No offence hughlss) Just think more recent news and graphs etc. could inspire more readers and therefore more discussion and interest. Thanks a lot, look forward to gettin more info on this company
mattyfromtheblock
01/6/2006
14:13
Nice to have somehting positive as the rest of portfolio can't seem to find anyhting cheerful about it. Do NUT do a supplement that helps stomach churning I wonder???
timis1
Chat Pages: 15  14  13  12  11  10  9  8  7  6  5  4  Older

Your Recent History

Delayed Upgrade Clock